SEC Form D · filed June 20, 2025
Indaptus Therapeutics, Inc
Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.
People & firms on this filing (22)
Anthony J. Maddaluna · JERUSALEM, L3DirectorHila J. Karah · NEW YORK, NYDirectorRobert E. Martell · NEW YORK, NYDirectorWalt A. Linscott · New York, NYExecRoger J. Pomerantz · JERUSALEM, L3DirectorWilliam B. Hayes · JERUSALEM, L3DirectorMark J. Gilbert · New York, NYDirectorRoger J. Waltzman · Austin, TXExecMichael J. Newman · New York, NYExec · DirectorJeffrey A. Meckler · JERUSALEM, L3Exec · DirectorNir J. Sassi · New York, NYExecAnthony J. Maddaluna · JERUSALEM, L3DirectorHila J. Karah · NEW YORK, NYDirectorRobert E. Martell · Lexington, MADirectorWalt A. Linscott · New York, NYExecRoger J. Pomerantz · Jupiter, FLDirectorWilliam B. Hayes · JERUSALEM, L3DirectorMark J. Gilbert · New York, NYDirectorRoger J. Waltzman · Austin, TXExecMichael J. Newman · New York, NYExec · DirectorJeffrey A. Meckler · JERUSALEM, L3Exec · DirectorNir J. Sassi · New York, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗